novo nordisk weight loss

Novo Nordisk, weight loss

Novo Nordisk next-gen shot shows 22% weight loss in early results

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their weight in 36 weeks, according to early-stage trial results on Friday, boosting the drugmaker's shares.

The Wall Street Journal on MSN · 2h

Novo Nordisk Shares Surge on New Obesity Drug Results

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients lost 22% of their bodyweight in a clinical trial.

Quartz on MSN · 50m

Novo Nordisk stock surges 12% as an Ozempic alternative shows promising weight loss

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight loss drug trial.

47m

Novo Nordisk Vaults Above LVMH as Europe's Biggest Company

Good news about an experimental weight-loss shot sent shares in Ozempic maker Novo Nordisk soaring, making it once again Europe's most-valuable listed company. A pullback in the Danish drug maker's ...

2hon MSN

Next-gen Novo Nordisk shot shows 22% weight loss in early results

One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...

STAT6d

High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Novo Nordisk, weight loss

Trending now